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Oxytocin (Oxt) is a neurohormone known for its physiological roles associated with
lactation and parturition in mammals. Oxt can also profoundly influence mammalian social
behaviors such as affiliative, parental, and aggressive behaviors. While the acute effects of
Oxt signaling on adult behavior have been heavily researched in many species, including
humans, the developmental effects of Oxt on the brain and behavior are just beginning to
be explored. There is evidence that Oxt in early postnatal and peripubertal development,
and perhaps during prenatal life, affects adult behavior by altering neural structure and
function. However, the specific mechanisms by which this occurs remain unknown. Thus,
this review will detail what is known about how developmental Oxt impacts behavior as
well as explore the specific neurochemicals and neural substrates that are important to
these behaviors.
Keywords: affiliative behavior, aggressive behavior, estrogen receptor alpha, maternal behavior, oxytocin receptor,
parental behavior, sexual behavior, vasopressin
Introduction
In the landmark paper by Phoenix et al. (1), the organizational effects of gonadal steroids on sexual
behavior in guinea pigs (Cavia porcellus) were established and resulted in the formulation of the
“organizational/activational hypothesis of sexual differentiation.” This hypothesis, which states that
perinatal exposure to gonadal steroids is important for the sexual differentiation of the brain and
behavior, is part of the foundation on which the field of behavioral neuroendocrinology has been
built. Given the importance of this concept, it is perhaps not surprising that in the last 55 years this
hypothesis has been extended to include another critical time period – puberty – as well as other
hormones and behaviors, with one of these hormones being oxytocin (Oxt) (2–4).
Oxytocin is a mammalian neurohormone composed of nine amino acids, known for its periph-
eral effects on parturition and lactation (5–7), as well as its central neuromodulatory effects on
social behaviors such as affiliative, aggressive, and parental behaviors (8, 9). While much of the
work on Oxt has focused on its involvement in the acute modulation of behavior, there is also
evidence that exposure to Oxt during early life is important for the proper development of neural
pathways and subsequent sex-specific behaviors. These latter observations have led researchers
to hypothesize that Oxt has organizational effects on the brain (3, 10). This is an exciting pos-
sibility as developmental exposure to Oxt appears to impact many of the species-specific and
sex-specific social behaviors it is known to modulate in adulthood – thus, a reevaluation and
broadening of our understanding of Oxt’s effects seems warranted. To encourage this shift in
paradigm, in this review we will highlight recent research on how developmental exposure to Oxt
affects behavior as well as the specific neurochemicals and neural substrates that underlie these
behaviors.
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Oxytocin’s Postnatal and Peripubertal
Effects on Behavior
Noonan and colleagues (10) were the first to hypothesize that
Oxt might have organizational effects on the brain and behav-
ior. Their work demonstrated that a single intracisternal injec-
tion of Oxt in postnatal day (PND) 3 rats (Rattus norvegicus)
significantly increases novelty-induced grooming at 4months of
age (10) [grooming is known to be directly enhanced by Oxt
administration in adults (11)]. However, when a study by Boer and
colleagues failed to replicate the aforementioned findings in an
open-field test (12), investigations into the organizational effects
of Oxt largely fell by the wayside. Yet, in the last 12 years, there
has been a resurgence of research in this area, with studies in
numerous species providing converging evidence that Oxt during
development can have permanent effects on the brain and behav-
ior (3, 13–29) (seeTable 1). The implications are profound, as they
are changing the way that we think about how Oxt works – no
longer as just a neuromodulator, but rather as a neurohormone
that contributes to the development of behaviors that are essential
for survival.
Sexual, Affiliative, and Aggressive Behaviors
Work in prairie voles (Microtus ochrogaster) has shown that there
are clear behavioral consequences when Oxt is manipulated dur-
ing early postnatal development, and that these effects are sex spe-
cific; this latter observation is perhaps not surprising since it is well
known that Oxt expression is sexually dimorphic in numerous
species, including prairie voles (30–34). In female prairie voles, a
single injection of Oxt on PND1 results in increases in intrasexual
aggression in adults, suggesting strengthened pair bond formation
(18), whereas an injection of both Oxt and an Oxt receptor antag-
onist (OTA), also on PND1, decreases the frequency of mating
bouts in both adult males and females (20). A single postnatal
injection of Oxt also increases intrasexual aggression in adult
female mandarin voles (Lasiopodomys mandarinus) after expo-
sure to a male (35). In male prairie voles, an injection of Oxt at
both low (1mg/kg) and high (4mg/kg) doses on PND0 increases
partner preference and social contact in adults compared to con-
trols (19, 36); however, a dose of 2mg/kg does not (36). Male
mandarin voles that receive a single postnatal injection of Oxt
increase their mounting behavior at PND60 (37). So, at least in
voles, developmental Oxt appears to increase pair bond formation
in females, and increase affiliative behaviors in males, whereas the
effects on sexual behavior appear to be stimulatory in both males
and females; though theymay be dose dependent in amanner that
is not linear.
In mice (Mus musculus), there are sex differences in the effects
of neonatal Oxt manipulation on affiliative behaviors, though
the findings differ from observations in prairie voles. Female
mice administered an OTA (3µg/20µL) on the day of birth have
decreases in social approach when tested at 8–15weeks (29) as
measured in a three chambered apparatus based on that developed
by Crawley (38). On the other hand, male mice administered an
OTA on PND0 display social approach behaviors similar to what
is observed in the control conditions (29). So, in mice it appears
that Oxt exposure in neonate females may promote affiliative
behaviors, while having no effect in males. Exploration of why
there may be no effect in male mice can be found in the section
titled “Potential Effects of Oxytocin During Fetal Development.”
The aforementioned impact of developmental Oxt on behavior
is not limited to rodents. Postnatal intranasal Oxt administration
in 2.5- to 8-week-old pigs (Sus scrofa) increases intrasexual aggres-
sive behavior and decreases social contact (39), which is similar to
what is observed in female prairie voles (18). [Pigs were selected
as an experimental model because their neuroanatomy, as well as
their physiology and development, ismore similar to humans than
rodent models (40).] This particular study is unusual in that it is
the only one to use an ungulate animal model, as well as one of
only a few studies to use intranasal Oxt administration. Because
of the uniqueness of this species, it is not known if these findings
are broadly applicable to other species.
There is also evidence that Oxt’s developmental effects on
sociabilitymay not be limited to the perinatal period, butmay also
extend into peripubertal development (2). Bowen and colleagues
administered daily Oxt injections to male rats from PND33 to
PND42 and then tested them in a social interaction test on
PND55. Oxt-treated males spent more time in close proximity to
conspecifics and made more active social contacts than controls
(41). Researchers from this same research group later conducted
an experiment in which male rats were given Oxt injections every
3 days from PND28 to PND55. When tested in a social interac-
tion test at PND70, their behavior appeared similar to what was
described above, with their spendingmore time in close proximity
to conspecifics than control animals (42). There have also been
studies investigating the effects of peripubertal intranasal Oxt on
behavior in rodents.Male prairie voles administered low,medium,
and high doses of intranasal Oxt daily during the approximate
time between weaning and sexual maturity, from PND21 until 42,
display increases in social contact during the treatment window,
and those given low and medium doses increase their preference
for strangers when tested from PND43–60 (43). In female BTBR
mice (a model of autism spectrum disorders), daily intranasal
Oxt treatment from PND21 to 50, followed by testing on PND55,
increases time spent sniffing a novel mouse over a novel object,
essentially rescuing “sociability” to levels observed in wild-type
mice (44). Another study found that chronic intranasal Oxt from
12 to 23weeks reduced social behavior in adult male mice when
they were tested 1 h after Oxt administration (45).While the stud-
ies described above may differ somewhat in terms of the details
of their findings, it does appear that intranasal Oxt treatment
during peripubertal development facilitates social interactions in
both males and females. However, it is not clear how long lasting
these effects are. Given that the peripubertal period is another
critical developmental window for the organizational effects of
hormones (2), more work focused on these types of questions
is needed, especially as intranasal Oxt is being considered as a
treatment for various neurodevelopmental conditions (46–48),
in particular children and adolescents diagnosed with autism
spectrum disorders (49–52).
Parental Behavior
Inmale prairie voles, treatmentwith anOTA inneonates decreases
alloparental behaviors. Specifically, males injected with an OTA
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TABLE 1 | A summary of the design and findings of studies investigating how developmental manipulation of oxytocin activity affects long-term behavioral
expression.
Species Treatment Age at
treatment
Age at assay Behavioral outcomes
in females
Behavioral outcomes in males Reference
Prairie vole 3.0µg Oxt i.p. PND0 PND60–90 ND Rescued social behavior diminished
by saline, " partner preference
(19)
Prairie vole 0.3µg OTA i.p. PND0 PND60–90 ND Rescued social behavior diminished
by saline
(19)
Prairie vole 3.0µg Oxt i.p. PND0 Adult " Aggression, # social behavior
after exposure to male
$ (18)
Prairie vole 0.3µg OTA i.p. PND0 Adult $ $ (18)
Prairie vole 3.0µg Oxt i.p. PND0 PND8 $ $ (23)
Prairie vole 0.3µg OTA i.p. PND0 PND8 # Ultrasonic vocalizations after
isolation
$ (23)
Prairie vole 3.0µg Oxt i.p. PND0–7 PND8 $ $ (23)
Prairie vole 0.3µg OTA i.p. PND0–7 PND8 " Ultrasonic vocalizations after
isolation
$ (23)
Prairie vole 3.0µg Oxt i.p. PND0 PND21 $ $ (14)
Prairie vole 0.3µg OTA i.p. PND0 PND21 $ # Parental behavior, " pup-directed
aggression
(14)
Prairie vole 3.0µg Oxt i.p. PND0 PND60 $ $ (14)
Prairie vole 0.3µg OTA i.p. PND0 PND60 $ $ (14)
Prairie vole 3.0µg Oxt i.p. PND0 PND75 # Mating bout frequency ND (20)
Prairie vole 0.3µg OTA i.p. PND0 PND75 # Mating bout frequency, " litter
production success
ND (20)
Prairie vole 1.0mg/kg Oxt i.p. PND0 PND55–69 $ ND (16)
Prairie vole 2.0mg/kg Oxt i.p. PND0 PND55–69 $ ND (16)
Prairie vole 4.0mg/kg Oxt i.p. PND0 PND55–69 " Pup retrievals ND (16)
Prairie vole 8.0mg/kg Oxt i.p. PND0 PND55–69 " Preference for stranger ND (16)
Prairie vole 750 nL CMV-Oxtr
NAcc-specific
PND21 PND60–88 " Parental behavior, " preference
for partner
ND (57)
Prairie vole 0.08 IU/kg Oxt
intranasally
PND21–42 PND43–60 $ " Preference for stranger (43)
Prairie vole 0.80 IU/kg Oxt
intranasally
PND21–42 PND43–60 $ " Preference for stranger (43)
Prairie vole 8.00 IU/kg Oxt
intranasally
PND21–42 PND43–60 $ $ (43)
Mandarin vole 3.0µg Oxt s.c. PND0 PND60–90 " Aggression after exposure to
male
" Social contact (35)
Mandarin vole 3.0µg Oxt s.c. PND0 PND60–90 " Preference for partner,
suppressed maintenance of
preference, # aggression toward
stranger
" Mounting of partner, # aggression
toward stranger
(37)
Rat 1.0µg/2.0µL Oxt
intracisternally
PND3–4 PND120 " Novelty-induced grooming " Novelty-induced grooming (10)
Rat 1.0mg/kg Oxt s.c. PND10–14 PND60–94 " Weight gain, " tail-flick
withdrawal latency
" Weight gain, " tail-flick withdrawal
latency
(63)
Rat 1.0mg/kg Oxt i.p.,
0.5µg EB
PND0–7 PND75 # Sexual receptivity ND (28)
Rat 1.0mg/kg Oxt i.p.,
5.0µg EB
PND0–7 PND75 # Sexual receptivity ND (28)
Rat 1.0mg/kg Oxt i.p.,
10.0µg EB
PND0–7 PND75 $ ND (28)
Rat 0.1mg/kg OTA i.p.,
0.5µg EB
PND0–7 PND75 # Sexual receptivity ND (28)
Rat 0.1mg/kg OTA i.p.,
5.0µg EB
PND0–7 PND75 $ ND (28)
(Continued)
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TABLE 1 | Continued
Species Treatment Age at
treatment
Age at assay Behavioral outcomes
in females
Behavioral outcomes in males Reference
Rat 0.1mg/kg OTA i.p.,
10.0µg EB
PND0–7 PND75 $ ND (28)
Rat 1.0mg/kg Oxt i.p. PND33–42 PND50–72 ND " Open-field exploration, " social
interaction, # ethanol consumption
(41)
Rat 0.5mg/kg Oxt i.p. PND28–55 PND70–72 ND " Social proximity (42)
Rat 1.0mg/kg Oxt i.p. PND28–55 PND70–72 ND " Social proximity (42)
Rat 0.5mg/kg TGOT i.p. PND28–55 PND70–72 ND $ (42)
Rat 1.0mg/kg TGOT i.p. PND28–55 PND70–72 ND $ (42)
Mouse 2.0µg Oxt s.c. PND0 PND1–3 Rescued feeding behavior in
Magel2 /  mice
Rescued feeding behavior in
Magel2 /  mice
(64)
Mouse 3.0µg OTA s.c. PND0 PND1–3 Lethal feeding deficiency Lethal feeding deficiency (64)
Mouse 3.0µg Oxt i.p. PND0 8–15weeks $ $ (29)
Mouse 0.3µg Oxt i.p. PND0 8–15weeks $ $ (29)
Mouse 3.0µg OTA i.p. PND0 8–15weeks # Parental care # Parental care (29)
Mouse 0.3µg OTA i.p. PND0 8–15weeks $ $ (29)
Mouse 0.15 IU Oxt
intranasally
12–23weeks 1 h post ND # Social behavior (45)
Mouse 0.30 IU Oxt
intranasally
12–23weeks 1 h post ND # Social behavior (45)
Mouse 0.80 IU Oxt
intranasally
PND21–50 PND55 Rescued diminished social
sniffing in BTBR mouse
$ (44)
Pig 50.0µg Oxt
intranasally
PND1–3 2–8weeks " Aggression " Aggression (39)
ND, no data; EB, estradiol benzoate.
within 24 h of birth and later tested on PND21 decrease their
parental care, as measured by fewer retrievals, less time spent
huddling over pups, and increases in pup-directed attacks. These
effects also appear to be transient, as they are not observed when
the same animals are tested again on PND60 (14). In laboratory
mice, treatment with an OTA also reduces alloparental care, but
in both sexes. Specifically, treatment with an OTA on PND0
decreases the total number of pups retrieved by females and
increases pup retrieval latencies in males (29). Oxt treatment also
increases the responsiveness of females to pups, as measured by
approach times, although this effect is dose dependent, with the
lowest dose of Oxt resulting in longer approach times compared to
saline controls (16). Thus, it appears that Oxt signaling is impor-
tant for normal displays of alloparental care, which is consistent
with its role in lowering the threshold for maternal care in rodents
(53–56).
Work by Keebaugh and Young has utilized viral vectors to
overexpress the Oxtr and study the organizational effects of Oxt
on behavior during puberty. By injecting an adeno-associated
viral vector into the nucleus accumbens (NAcc) shell of female
prairie voles at PND21 they were able to facilitate alloparental
care, as measured by reductions in approach times and increases
in time spent licking and grooming pups compared to con-
trols (57). This gene delivery approach has helped to identify
a specific neural substrate – the NAcc – on which Oxt may
act. The NAcc, which is a part of the brain’s reward circuit, is
known to be important in numerous motivated behaviors – it
not only expresses the Oxtr but is also one of the regions in
which the Oxtr is more highly expressed in biparental prairie
voles compared to non-monogamous species that do not exhibit
biparental care (58–62).
Other Behaviors
While only a few studies have investigated Oxt’s organizational
effects on other behaviors, these studies confirm that Oxt’s devel-
opmental effects are not limited to its impact on social behavior. In
rats, repeated administration of Oxt between PND10 and PND14
results in weight gain in both males and females, increases in
the gut hormone cholecystokinin, and longer withdrawal laten-
cies in the tail-flick test at PND60, which suggests an increase
in pain threshold (63). Male and female mice with a genetic
disruption that models Prader–Willi syndrome usually exhibit a
lethal feeding deficiency. This feeding deficiency can be rescued
with an injection of Oxt on PND0, or induced in wild-type mice
by injecting an OTA 1–1.5 h after birth (64). These observations
are consistent with what is observed in Oxt and Oxtr knockout
( / ) mice. These mice develop late-onset obesity in the absence
of hyperphagia (65, 66). However, these developmental effects of
Oxt differ from what is observed in adults, where Oxt is hypoth-
esized to have anorexigenic effects (67). Since developmental Oxt
appears to impact aspects of energy homeostasis, which in turn
can affect behavior, additional work in this area is warranted.
Finally, in the study by Bowen and colleagues (41)mentioned in
the previous section, peripubertal Oxt administration also affects
anxiety-like behavior and ethanol consumption later in life. Male
rats given daily Oxt injections from PND33 to PND42 and tested
in an emergence test on PND50 traveled further and spent more
time in the open-field compared to controls, which would suggest
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thatOxt had an anxiolytic effect.When tested on PND72 and later,
Oxt-treated males consumed significantly less alcohol (i.e., beer)
than controls, while water consumption remained unaffected (41).
Summary
It is apparent that Oxt in early postnatal development and during
puberty can result in long-lasting changes in behavior, including
behaviors that have traditionally been associated with Oxt’s acute
neuromodulatory effects, such as affiliative and sexual behaviors,
as well as non-social behaviors, such as nociception and ethanol
consumption. While there is a lack of consensus in the data, this
is in part a reflection of the difficulty of these types of studies, as
there are many experimental possibilities that could result in very
different outcomes. Particularly crucial is the timing window for
Oxt administration, the dose of Oxt, and the behavioral endpoints
measured. It is also important to note that Oxt’s organizational
effects appear to be sex- and species-specific, which is consistent
with the complexity of its neuromodulatory role in adulthood.
Thus, future behavioral work will need to continue to take a broad
approach to identify Oxt’s potential organizational effects, as some
of these behavioral changes, such as energy metabolism and anx-
iety, could affect a variety of other behaviors. In the meantime,
rigorous investigation of Oxt’s organizational effects on neural
structure and functionmay help clarifymechanisms by whichOxt
affects brain development and ultimately behavior.
Oxytocin’s Developmental Effects on
Neurochemicals and Neural Substrates
The behavioral effects of postnatal and peripubertal Oxt must be
rooted in structural and functionalmodifications to neurons, such
as changes in gene expression, axonal guidance, or cell morphol-
ogy. Therefore, in this section, we review what is known about
how Oxt may be impacting these systems.
Effects on Estrogen Receptor Alpha
It is well established that gonadal steroids play a significant role
in regulating Oxt activity (68–71). While androgens and proges-
terone modulate Oxt and Oxtr expression (72–75), it is the estro-
gens that seem to have the greatest impact on the Oxt system (68,
70, 74, 76–78). Further, these effects are not unidirectional, with
the Oxt system altering gonadal steroid systems, specifically the
expression of estrogen receptor α (ERα). Neonatal injections of
Oxt increase ERα expression in the ventromedial hypothalamus
(VMH) of adult females and Oxt treatment on PND0 increases
the number of ERα-immunoreactive (ERα-ir) cells in the VMH
of 3-week-old prairie voles (26). These effects appear to be rapid
since neonatal prairie voles treated with Oxt also have increases
in ERα-ir (24, 79) and ERα mRNA expressions (79). Similar
to prairie voles, rats that are repeatedly administered Oxt from
PND0 until PND7 have increases in ERα-ir at PND75 (28) and
neonatal Oxt manipulation increases the expression of ERα in
the hippocampus (79), ventral lateral septum (LS), and central
nucleus of the amygdala (24). These results differ from reports in
females where a single injection of an OTA on PND1 decreases
expression of ERα in the medial preoptic area (MPOA) of adult
female prairie voles, as well as increases ERα expression in the
BNST, and possibly decreases expression in the medial amygdala
(MeA) (26) and repeated administration of an OTA from PND0
to PND7 decreases the expression of ERα in the MPOA of adult
female rats (28).
Effects on the Oxytocin and Vasopressin Systems
Early exposure to relevant stimuli is known to permanently alter
the responsiveness of a hormone receptor; this phenomenon is
known as hormonal imprinting (80). Based on this observation,
it is reasonable to suspect that early Oxt exposure could affect the
development of the Oxt system itself. Data from several species
clearly support this idea; however, the findings are not consistent
between sexes and species – in keeping with Oxt’s known inter-
sexual and interspecific variation. In female prairie voles, neonates
treated with Oxt and an OTA have increases in Oxt immunoreac-
tivity (Oxt-ir) within the PVN by 3weeks of age. Yet, inmales, Oxt
has no effect on Oxt-ir, but treatment with an OTA does decrease
arginine vasopressin (Avp) immunoreactivity in the PVN (27).
In addition to changes in peptide expression, neonatal manip-
ulation of Oxt impacts Avp 1a receptor (Avpr1a) binding in a
sexually dimorphic manner. Specifically, in female prairie voles,
Oxt treatment on PND0 decreases Avpr1a binding in the MPOA,
BNST, LS, cingulate cortex (CgCtx), and medial thalamus on
PND60, but in males it increases Avpr1a binding in the CgCtx.
OTA treatment in females decreases Avpr1a binding only in the
BNST and CgCtx, while in males it decreases Avpr1a binding in
the MPOA, BNST, and LS (15). Taken together, the delivery of
Oxt or an OTA during early postnatal life appears to have nearly
opposite effects on adult Avpr1a expression in females and males.
Similar to what was discussed in terms of behavioral effects, there
does appear to be a “critical period” of organization that extends
into peripubertal development, with peripubertal Oxt administra-
tion increasing Oxtr mRNA expression in the hypothalamus (41)
and plasma Oxt levels (42) in adult male rats.
Other Effects
While studies on the organizational effects of Oxt on other neuro-
chemical systems are few and far between, there is evidence that
perinatal exposure to Oxt can influence the functioning of the
stress axis. Female prairie voles administered Oxt on PND1 have
reductions in baseline plasma corticosterone by PND8 compared
to animals treated with saline or an OTA (23). In neonatal pigs,
repeated Oxt treatment increases adrenocorticotropic hormone
(ACTH) at 8weeks of age and decreases responsiveness in the
dexamethasone suppression test at 11weeks; indicative of dysreg-
ulation of the glucocorticoid response. However, pigs that receive
Oxt have less blunting of the cortisol response than controls (39).
So, not only is Oxt able to acutely regulate stress responses (81, 82)
but appears to also be involved in the development of long-term
responsiveness to stress.
There are also reported effects of neonatal Oxt on adren-
ergic and serotonergic receptors, which may contribute to the
aforementioned effects of Oxt on feeding and social behaviors
(see Other Behaviors). In rats, chronic neonatal Oxt treatment
alters α2 adrenergic receptor (α2r) kinetics in PND130 male rats;
these changes are dependent upon the nutrition of the dam to
which the pups were born. Specifically, Oxt treatment rescues
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the affinity (described by the dissociation constant Kd), which
is decreased in placebo treated neonates of food-restricted dams
compared to offspring of dams fed ad libitum, of the α2r for
its ligand within the nucleus of the solitary tract (NTS) and
increases the number of α2r binding sites (described by Bmax)
in the hypothalamus and amygdala of offspring born to food-
restricted dams compared to controls. In pups born to dams
fed ad libitum Oxt treatment decreases the affinity of the α2r
for its ligand in the hypothalamus, and increases the number of
binding sites in the hypothalamus and NTS (83). In male prairie
voles, neonatal Oxt administration also results in increases in
serotonergic axon density in the anterior hypothalamus, corti-
cal amygdala, and VMH at PND21 (21), as well as decreases
dopamine turnover in the hypothalamus as well as serotonin
turnover in the hypothalamus,medulla oblongata, and striatum of
4-month-old female rats (84). Thus, not only does developmental
Oxt exposure affect many different neural circuits, these effects
can also be highly dependent on the state of the dam. This is
in keeping with a large body of research showing that maternal
physiology, particularly stress (85–87) and nutrition (88–90), can
greatly impact the neural and behavioral development of off-
spring. The previously described studies have opened the door
to exploring what role developmental Oxt might play in these
effects.
Summary
The organizational effects of Oxt extend to many different neu-
rochemical systems including the gonadal steroids, the Oxt and
Avp systems, and the stress axis, which suggests that Oxt’s effects
are widespread and complex (Figure 1). The brain regions most
commonly affected by developmental Oxt exposure are the VMH,
MPOA, BNST, LS, PVN, and several nuclei of the amygdala. Oxt
or the Oxtr is expressed in some of these regions (68, 91), though
their expression in these brain areas often varies depending on
species, age, and sex. What is particularly interesting about the
aforementioned brain nuclei is that many of them are a part
of the “social behavioral network,” which is comprised of neu-
roanatomical areas or “nodes” that are interconnected, express
gonadal hormone receptors, appear to be influenced by Oxt, and
are important in the regulation of many types of social behaviors
(92, 93). Work from Bruce Cushing’s laboratory suggests that the
BNST and MeA are particularly important for the developmental
effects of Oxt and ERα on social behavior (24, 26, 94) but further
investigation into the entire social behavioral network is needed.
Potential Effects of Oxytocin During Fetal
Development
While research into the neonatal and peripubertal developmental
effects of Oxt has been ever increasing, an area that remains
largely unexplored is the potential for Oxt to have organizational
effects during embryonic development. These potential effects are
relevant, in part, because of the increased use of Oxtr agonists,
such as Pitocin, and antagonists, such as Atosiban, during human
pregnancy in order to manage labor timing (95, 96). While the
developmental consequences of these interventions have been
reviewed elsewhere (95), the possible behavioral implications of
exposing human fetuses to exogenous Oxt or Oxtr antagonists
should not be ignored. Because of the complexity and ethical
considerations in humans our best hope for elucidating the role
of fetal Oxt is the use of animal models.
In mice, there is evidence that in utero exposure to Oxt is
important for normal intermale aggressive behavior in adulthood.
Specifically, male Oxt /  mice that are born to null mutant dams
show heightened aggressive behavior in adulthood (97, 98).While
this phenotype cannot be rescued if the pups are cross-fostered to
wild-type dams (99), it is not observed when male mice are born
to heterozygous dams. One of the key differences between pups
born to null mutant dams versus those born to heterozygous dams
is the absence or presence of maternal Oxt. The hypothesis that
the maternal Oxt may be signaling in the fetal brain is supported
by studies using male Oxtr knockout (Oxtr / ) mice, which lack
Oxtr signaling throughout development. These mice also have
heightened aggressive behavior in adulthood (99, 100). However,
male forebrain Oxtr knockout (Oxtr Fb/Fb) mice (101, 102), in
which theOxtr gene is excised 21–28 days after birth, have normal
aggressive behavior in adulthood (100). These data suggest that
Oxt signaling via the Oxtr during fetal development might be
important for displays of aggressive behavior, and perhaps other
behaviors in adulthood.
Unfortunately, very little is known about the developmental
time course of the Oxt system in rodents. In rats, Oxt mRNA
is observed as early as embryonic day (E) 15.5 in the PVN and
E18.5 in the SON (103). The mRNA for the Oxt carrier protein
neurophysin-I is available as early as E16 in the PVN and SON,
FIGURE 1 | Developmental exposure to oxytocin is known to affect many
behaviors (left) and neurotransmitter and neurohormone systems (right).
These behavioral effects are often species and sex specific, which is consistent
with oxytocin’s neuromodulatory role in adults. However, how these behavioral
changes are rooted in the observed alterations in neurochemistry remains
unknown.
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and theOxt peptide is seen by PND7 in the SONandPVNandE21
in the pituitary (104). Prairie voles also have a postnatal increase
in Oxt peptide expression, with the number of Oxt expressing
neurons significantly increasing from PND1 to PND21 in both
males and females (27). While less is known about the develop-
ment of the Oxtr, in rats, Oxtr binding has been identified as
early as E14 in undifferentiated neurons (104). In mice, a study
by Hammock and Levitt (105), which focused primarily on Oxtr
binding during postnatal development, found Oxtr binding in
the brains of E18.5 C57BL/6J mice. However, this was the only
embryonic time point that was examined. It is plausible that the
“critical window” for themanipulation of theOxt system is not the
same in males as in females, since there could be sex differences
in its development. Therefore, future research in this area should
consider the potential for sex differences in the development of
the Oxt system, as it may help to inform the conclusions that are
drawn from the data.
Conclusion
Compared to what we understand about Oxt in adulthood,
research into its role in development is still in its early stages and
there is much to do before we really have a handle on its effects
on the brain and behavior. For instance, what other behaviors are
affected? How conserved are Oxt’s effects across species, or within
a particular sex? How are these organizational changes grounded
in alterations of neuronal structure and function? How broad is
the “critical window” for Oxt’s effects? What are the implications
for human offspring? Therefore, examination of the mechanisms
that may underlie behavioral changes, including the identification
of specific neural substrates, is of the utmost importance.
This is an exciting time in behavioral neuroendocrine research
due to increased interest inOxt and the social brain as well as great
advancements in the foundational work, which has methodically
examined the neuromodulatory effects of Oxt in animal models.
However, there is still much we do not understand about the Oxt
system, and filling this “knowledge gap” becomes more vital as
the interest in using Oxt in clinical settings continues to increase.
For the last several years, intranasal Oxt has been marketed as
the “cuddle” or “love” hormone, and is being used in a variety of
contexts as a therapeutic agent to promote prosocial behaviors in
humans. Much of this work has been performed in the absence of
dose response studies, without serious consideration of the poten-
tial developmental or long-term effects, and with little attention
paid to where in the brain these effects might be mediated. Thus,
it is perhaps not surprising that more recent studies in humans
suggest that Oxt’s effects are nuanced (as the data from animal
models would suggest) and that intranasal Oxt treatment can have
undesirable effects (106–108). In light of this, basic research on
the Oxt system becomes ever more critical, particularly since our
understanding of the developmental role of Oxt is expanding. An
important first step is to home in on specific circuits, focusing on
studies that will shed light on the interactions between numerous
brain regions and behaviors. This approach will allow scientists to
elucidate the specific mechanisms of Oxt’s organizational effects
on behavior – be they genetic, epigenetic, or neuroanatomical –
which can then be used not only to inform human studies but also
identify any conserved mechanisms between sexes and species.
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